Member Info for VikR

Just added to my existing shares yesterday in the 0.30 dip. With the assets these guys have, near term potential and the hugely underserved field it operates in makes this investment case faultless. As a pharmacist

myself some of my recent investments of late into UK scientific companies such as this, FAB fusion antibodies, APTA demonstrates the importance in evidence based decision making in selecting your shares. Good luck all vested astute investors

I have just topped up another 1 million share to my existing holding. Huge holder here and at FAB fusion antibodies with Mr Kinkaid been involved in both businesses. One is novel word class antibodies and the other is world class non antibody alternatives. Both have there place in the biotech world and I hope they excel respectively with multi million big Pharma deals around the corner. Good luck astute investors

Hi

You have been a very loyal investor and I can understand your grievance from historical performance be that of the board/ Mc Mcarthy et al. The only difference now is they have actually understood the principle on a cellular level on how p140 works. Additionally using it as a diagnostic aid can help target the treatment to those who will respond to it most. They simply did not have that research to hand in the last failed clinical trial. It won’t work for everyone but it will be good enough to make it commercially viable. Unfortunately with such new data to hand arranging patent logistics is the limiting factor hence we have not heard anything yet. Big Pharma don’t want to commit until this is lodged. Sometimes no news is better esp when the team are working hard in the background to secure the best terms possible. They cannot hide anything negative from the market so for the doubters worried about lack of news flow take it as a positive for now.

Just added another 5k to my holding. With the number of multi billon dollar deals being done this arena just a matter of time before imm’s time comes to fruition. After previous mistakes/ errors with the failed p140 trial failure is no longer an option so they are taking time to get it right this time with the revised dosing and administration methods coupled with deeper understanding into the MOA they have recently researched. Load up and sit back and forget about this share until the mega RNS lands. Whilst Mr McCarthy has made previous mistakes in his career this time he is getting it right. Good luck ALTHs

The share price will now speak for itself as it gains traction with the new investor pool. Astute investors with share price acumen and perhaps with a baseline scientific knowledge will appreciate what is on offer here. Fully humanised antibodies from the beginning of manufacture. As per the Fusion motto ‘begin with the end in mind’

The technicals have finally aligned with the sentiment and fundamentals after many months. This is only going unilaterally upwards trajectory before year end 2025

For those that do not understand the scientific principles behind the product I can empathise with your skepticism. FAB are developing products in the antibody market which is the biggest Pharma revenue generating area for the last 2 years. Antibodies give real bang for buck and exert maximal therapeutic benefit when finessed aptly hence their appeal . Last year there was like 115 billion attributed to this market alone. If a new company can get to clinical trials quicker with technologies like optimal then it saves the millions in the manufacturing process. This is why you really have to exercise perseverance and dedication to this share because it will explode whether that happens now, next month or next year. Be brave and bold astute investors and do not let the 1-2p up and down phase your long term gains. Any newbie investors welcome and I wish you good fortune, success and know your part of the pioneering journey.

Very confident accumulate and hold now. The board will be faced with many decisions on contracts with big pharmaceutical companies or an outright sale of all the tech or even individual parts. They will navigate to ensure the best deal is done to reflect the true value of the tech. A solid position of negotiation to be in for them

The best unofficial endorsement from our CSO himself. You don’t promote a conference on your topic with a product that won’t work. So there we have it astute investors the pieces of the puzzle all coming together all while we have a chance to load up sub 10p. This tech is the worlds first, our competitors simply don’t have anything to

Stt1 you have been absent from this board for many months. As soon as we are nearing anticipated milestones you seem to spout negative sentiment. I certainly have no time for it and believe you have some other agenda to bring in negativity into a company which has viable prospects. Please spread your misinformation to your own family and friends and not on public forums. All the genuine posters have sent evidence based statements and factual information. As a scientist myself I strongly believe in the science and its massive capabilities, I have no doubt in my mind. Do the right thing stt1 and walk away with your unfounded flawed claims

I believe you do the same here, since I’ve purchased this share you seem to bombard it positive comments whereby in reality the SP hasn’t shifted in many months irrespective of the RNS’s that have landed. Perhaps you should have a more global rounded perspective before reviewing my posts

Dear Laura

I am not spamming, which by definition is sharing indiscriminately or unsystematically. I am simply sharing my subjective knowledge and not forcing anyone to buy. I myself have purchased £50k in cash or these shares this morning so I practice what I preach. Meanwhile I advise you stick to PYC where I am also invested but seems to be at the 0.5p even in the face of RNS after RNS for the last 8 months.

The results speak for themselves already up 23% in a day, just sharing my subjective take on the current hot share of the moment. Nice to make money wherever we can and share the knowledge of genuine worthy investments where possible

For the technical chart analysts out there look at the gap to 37.5 p back in May 2023. That was its long term support for a decent few months in this region. It’s plausible to get here quite quickly on the first iteration of news flow so believe me folks when I say be patient and hold before contemplating selling any of your valuable shares brought sub 10p.

As a pharmacist interested in tech this definitely has legs but the transformational RNS needs to land one day to see some significant gains into hopefully double figures. On an another note FAB fusion antibodies has an imminent RNS due confirming patent grant confirmation. It’s been on the US website since this morning so only matter of time they have to make it official. That will rise super fast , luckily loaded up today

This was always going to go unilaterally and most of all this is just the beginning. For the discernible investor now is the time to accumulate and hold and don’t be tempted for the few pennies you may see go up but wait for the step transformation into big figures. Additionally take humility from the fact you are part of revolutionary scientific discovery.

Hopefully the news starts incoming of some commercialisation so we can see some serious upward trajectory. Mr Adrian Kinkaid ex business chief officer of APTA has moved onto FAB fusion antibodies as CEO and is making some big moves there. Loaded up this morning and already 23% up as patent notification has been uploaded on the US website so just a matter of time they have to RNS it officially and then watch the share price fly, I would load up astute investors.

Got tempted to buy back in this morning on the bell hoping it doesn’t drift much further down. Also purchased heavy at FAB fusion antibodies this morning as they have announced issue notification for patent on US website for there flagship tech so loaded up before they have to officially RNS it. Hoping both of these can give me big rises to make early retirement a reality.

Just invested some into here not had a chance to delve into the fundamentals yet but hopefully proves to be a wise move. Also loaded on FAB fusion antibodies this morning who have just had an issue notification for their patent on US website so expect an exponential similar rise when they have to formally RNS it asap. Best of luck astute investors

A period of consolidation and calm before the next leg up seems to be here. On another note FAB fusion antibodies has just had its issue notification published on website for patent grant. Loaded up there fast this morning before it is officially announced via RNS, fill your boots astute investors.